Acertara Acoustic Laboratories, Longmont, Colo, announced on August 25 that it has been granted US patent no. 8,803,532 related to a new system for testing diagnostic ultrasound probes.
“This patent represents the 15th patent our team has been awarded relative to diagnostic ultrasound system and probe testing devices,” G. Wayne Moore, president and CEO of Acertara, said in a press release. “Our engineering team first developed the modern ultrasound probe testing paradigm more than 13 years ago when we introduced FirstCall at Sonora Medical Systems. It is our passion to once again redesign the probe testing market by creating disruptive technologies that match the very complex and sophisticated ultrasound probes being used today, including 2D matrix arrays.”
The Acertera research and development team has been awarded more than 40 patents ranging from 3D ultrasound devices to devices that deliver super-saturated levels of oxygen to myocardial tissue of heart attack patients.